Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-HIV”

662 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 662 results

Not applicableStudy completedNCT00886990
What this trial is testing

Efficacy and Safety of Single Versus Double Ritonavir-boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens

Who this might be right for
HIV InfectionHIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 240
Post-approval studies (Phase 4)Ended earlyNCT01676363
What this trial is testing

Pilot Study of Diflunisal in HIV-infected Adults

Who this might be right for
HIV Infection
University of British Columbia 8
Testing effectiveness (Phase 2)Study completedNCT01775475
What this trial is testing

Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma

Who this might be right for
AIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell LymphomaAIDS-related Diffuse Small Cleaved Cell Lymphoma+6 more
AIDS Malignancy Consortium 7
Large-scale testing (Phase 3)Study completedNCT00460746
What this trial is testing

Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.

Who this might be right for
HIV
Tibotec, Inc 10
Post-approval studies (Phase 4)Study completedNCT00245986
What this trial is testing

Effect of Genetics on Metabolism of Efavirenz

Who this might be right for
Metabolism
National Institutes of Health Clinical Center (CC) 350
Large-scale testing (Phase 3)Study completedNCT03446573
What this trial is testing

Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)

Who this might be right for
HIV Infections
ViiV Healthcare 743
Not applicableNot Yet RecruitingNCT07390409
What this trial is testing

ALIGN: A Non-randomised Study Delivering Injectable Lenacapavir for HIV Prevention Within a Pre-exposure Prophylaxis (PrEP) Choice Context in Cape Town, South Africa.

Who this might be right for
HIV
Desmond Tutu HIV Foundation 3,700
Not applicableStudy completedNCT02342769
What this trial is testing

Prospective Non-Interventional Observational Study of Use of TRIUMEQ and Corresponding Monitoring Measures in Clinical Practice in Germany

Who this might be right for
HIV Infections
ViiV Healthcare 403
Large-scale testing (Phase 3)Study completedNCT00454337
What this trial is testing

Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 170
Testing effectiveness (Phase 2)Study completedNCT00251537
What this trial is testing

A Pilot Study of LTB4 in HIV-1 Infected Adults

Who this might be right for
HIV Infections
LTB4 Sweden AB 40
Large-scale testing (Phase 3)Study completedNCT05917509
What this trial is testing

Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

Who this might be right for
HIV Infections
ViiV Healthcare 171
Not applicableNot Yet RecruitingNCT05771519
What this trial is testing

Developing an HIV Disclosure Intervention for Men in Uganda

Who this might be right for
HIV InfectionsSexually Transmitted Infections (Not HIV or Hepatitis)
Brigham and Women's Hospital 70
Post-approval studies (Phase 4)Study completedNCT01599364
What this trial is testing

Atazanavir/r + Lamivudine Dual Therapy

Who this might be right for
Human Immunodeficiency Virus
Catholic University of the Sacred Heart 266
Not applicableUnknownNCT05359471
What this trial is testing

Characterization of Visceral Adiposity in HIV Mono-infected Patients With NAFLD

Who this might be right for
Visceral SteatosisHivNAFLD
McGill University Health Centre/Research Institute of the McGill University Health Centre 30
Not applicableStudy completedNCT00884793
What this trial is testing

Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut

Who this might be right for
HIV Infections
University of California, San Francisco 8
Early research (Phase 1)Active Not RecruitingNCT02337985
What this trial is testing

Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma

Who this might be right for
AIDS-Related Burkitt LymphomaAIDS-Related Diffuse Large B-cell LymphomaAIDS-Related Plasmablastic Lymphoma+3 more
City of Hope Medical Center 10
Post-approval studies (Phase 4)Looking for participantsNCT07138144
What this trial is testing

Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up

Who this might be right for
HIV Infections
José Antonio Mata Marín 156
Post-approval studies (Phase 4)Study completedNCT00116116
What this trial is testing

DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Who this might be right for
HIV InfectionsAIDS
Bristol-Myers Squibb 70
Post-approval studies (Phase 4)Study completedNCT00192660
What this trial is testing

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Who this might be right for
HIV-Associated Lipodystrophy SyndromeCardiovascular Disease
Kirby Institute 80
Not applicableLooking for participantsNCT06834113
What this trial is testing

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Who this might be right for
HIV I InfectionInjection Pain
Centre Hospitalier Régional d'Orléans 120
Next Page